Frigate Ventures »

Atea Pharmaceuticals shares owned by Frigate Ventures

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Frigate Ventures from 13F filings

Historical chart of Frigate Ventures investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Frigate Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Frigate Ventures

Quarter filed Position value Share count Share price at filing
2023-09-30 $150k 50k 3.00
2023-06-30 $187k 50k 3.74
2021-12-31 $477k 53k 8.94

More positions owned by Frigate Ventures

Tempur Sealy International Equity (TPX)
AdvisorShares Pure US Cannabis ETF Exchange Traded Fund (MSOS)
Nano Dimension Adr (NNDM)
Blockchain Coinvestors Acquisition Corp I Warrant (BCSAW)
iShares U.S. Real Estate ETF Exchange Traded Fund (IYR)
iShares 20 Year Treasury Bond ETF Option Call Option (TLT)
SPDR S&P 500 ETF Trust Option Put Option (SPY)
iShares iBoxx High Yield Corporate Bond ETF Option Put Option (HYG)
Block Option Call Option (SQ)
Activision Blizzard Equity
Oncolytics Biotech Equity (ONCY)
Vivid Seats Equity (SEAT)
iShares China Large-Cap ETF Option Call Option (FXI)
Invesco QQQ Trust Series 1 Option Put Option (QQQ)
Tricon Residential Option Call Option (TCN)

View all positions for Frigate Ventures

Top funds holding Atea Pharmaceuticals

BlackRock
EcoR1 Capital
FMR
BML Capital Management
Vanguard Group
Tang Capital Management
Bain Capital Life Sciences Investors
Geode Capital Management
Acadian Asset Management
Northern Trust
Jacobs Levy Equity Management
Charles Schwab Investment Management
Federated Investors
Two Sigma Advisers
Susquehanna International

View all funds holding Atea Pharmaceuticals